A Phase 1/2a, Open-Label, Dose-Escalation Study to Evaluate the Safety and Preliminary Efficacy of TRX319 in Subjects With Primary or Secondary Progressive Multiple Sclerosis
NCT07477639 · RECRUITING · Phase 2
We track 1 ClinicalTrials.gov studies led by Tr1x Inc. The portfolio skews toward Phase 2 (1 trials).
1 clinical trials sponsored by Tr1x Inc.
| Phase | Trials | Distribution |
|---|---|---|
| Phase 2 | 1 | 100% |
Tr1x Inc currently sponsors 1 clinical trials tracked on ReadTheTrial. These span Phase 2.
Tr1x Inc conducts research across multiple therapeutic areas. Browse the trial listings for details.
Yes, Tr1x Inc currently has 1 trial that are actively recruiting participants. Check individual trial pages for eligibility criteria and locations.